• Our Members
  • Media Room
  • Events
  • Contact us
AMR Industry Alliance
  • About us
    • Why the AMR Industry Alliance?
    • How we work
  • Shared Goals
    • AMR Industry Declaration
    • Industry Roadmap for Progress on Combating Antimicrobial Resistance
    • Responsible Manufacturing
  • Why AMR?
  • Progress Report
  • Press Releases
  • In Action
Select Page
AEQUOR’S NOVEL MOLECULES COUNTER BIOFILM ASSOCIATED WITH HOSPITAL-ACQUIRED INFECTIONS

AEQUOR’S NOVEL MOLECULES COUNTER BIOFILM ASSOCIATED WITH HOSPITAL-ACQUIRED INFECTIONS

by Morgane De Pol | Feb 10, 2020

MOBIDIAG’S FAST SCREENING TEST IDENTIFIES RESISTANT BACTERIA, ASSESSES PATIENT CONDITION

MOBIDIAG’S FAST SCREENING TEST IDENTIFIES RESISTANT BACTERIA, ASSESSES PATIENT CONDITION

by Morgane De Pol | Feb 10, 2020

ANTIBIOTIC ADJUVANT’S ELECTRONIC TOOL REDUCES ANTIBIOTIC MISUSE IN THE LONG-TERM CARE SECTOR

ANTIBIOTIC ADJUVANT’S ELECTRONIC TOOL REDUCES ANTIBIOTIC MISUSE IN THE LONG-TERM CARE SECTOR

by Morgane De Pol | Feb 10, 2020

NovaDigm Therapeutics

NovaDigm Therapeutics

by Morgane De Pol | Dec 11, 2019

Alphanosos

Alphanosos

by Morgane De Pol | Oct 16, 2019

« Older Entries

stay informed

Subscribe to receive our updates

about us

The AMR Industry Alliance brings together biotech, diagnostics, generics and research-based pharmaceutical companies, to drive and measure industry progress to curb antimicrobial resistance.

read more
contact

AMR Industry Alliance Secretariat (IFPMA)
Chemin des Mines 9
P.O. Box 195
1211 Geneva 20
Switzerland
Email: info@amrindustryalliance.org

© AMR Industry Alliance 2017 - Contact us - Cookies Policy - Privacy Policy - Terms of use - Privacy Centre - Careers